• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】38987

【品名】5-bromopyrimidine

【CA登记号】4595-59-9

【 分 子 式 】C4H3BrN2

【 分 子 量 】158.9853

【元素组成】C 30.22% H 1.9% Br 50.26% N 17.62%

与该中间体有关的原料药合成路线共 3 条

合成路线1

该中间体在本合成路线中的序号:(I)

Palladium-catalyzed coupling of 5-bromopyrimidine (I) with ethyl acrylate (II) afforded pyrimidinyl acrylate (III), which was hydrogenated over Pd/C to give (IV). Claisen condensation of (IV) with ethyl formate furnished oxoester (V). This was then cyclized with thiourea (VI) to produce the intermediate thiouracil (VII).

1 Hickey, D.M.B.; Boyd, H.F.; Flynn, S.T.; et al.; 2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2. Bioorg Med Chem Lett 2000, 10, 4, 395.
2 Pinto, I.L.; Ife, R.J.; Hickey, D.M.B.; Smith, S.A.; Leach, C.A.; Porter, R.A. (SmithKline Beecham plc); Pyrimidinone cpds. and pharmaceutical compsns. containing them. EP 1028955; WO 9924420 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 38987 5-bromopyrimidine 4595-59-9 C4H3BrN2 详情 详情
(II) 10164 ethyl acrylate 140-88-5 C5H8O2 详情 详情
(III) 38988 ethyl (E)-3-(5-pyrimidinyl)-2-propenoate C9H10N2O2 详情 详情
(IV) 38989 ethyl 3-(5-pyrimidinyl)propanoate C9H12N2O2 详情 详情
(V) 38990 ethyl (Z)-3-hydroxy-2-(5-pyrimidinylmethyl)-2-propenoate C10H12N2O3 详情 详情
(VI) 10180 Thiourea 62-56-6 CH4N2S 详情 详情
(VII) 38991 5-(5-pyrimidinylmethyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone C9H8N4OS 详情 详情

合成路线2

该中间体在本合成路线中的序号:(II)

The protected 4-pyrimidinylphenylalanine (III) was prepared by palladium-catalyzed coupling of the boronophenylalanine (I) with the 5-halopyrimidine (II). After acidic cleavage of the N-Boc protecting group of (III), the resultant amino ester (IV) was coupled with N-Boc-cycloleucine (V) to provide dipeptide (VI). Further acidic treatment of (VI) removed the N-Boc group to yield amine (VII). The chiral bromo acid (IX) was obtained by diazotization of D-valine (VIII) in the presence of HBr and KBr. Acylation of the racemic amine (VII) with bromo acid (IX) furnished the corresponding amide (X) as an epimeric mixture. The bromo group of (X) was finally displaced with potassium thioacetate to give the title thioacetate ester.

1 Gude, C.; Chan, K.; Firooznia, F.; et al.; Synthesis and biological activity of novel potent endothelin-converting enzyme-1 inhibitors. Bioorg Med Chem Lett 2001, 11, 3, 375.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 47701 methyl 2-[(tert-butoxycarbonyl)amino]-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate C21H32BNO6 详情 详情
(II) 38987 5-bromopyrimidine 4595-59-9 C4H3BrN2 详情 详情
(III) 47702 methyl 2-[(tert-butoxycarbonyl)amino]-3-[4-(5-pyrimidinyl)phenyl]propanoate C19H23N3O4 详情 详情
(IV) 47703 methyl 2-amino-3-[4-(5-pyrimidinyl)phenyl]propanoate C14H15N3O2 详情 详情
(V) 30890 1-[(tert-butoxycarbonyl)amino]cyclopentanecarboxylic acid C11H19NO4 详情 详情
(VI) 47704 methyl 2-[([1-[(tert-butoxycarbonyl)amino]cyclopentyl]carbonyl)amino]-3-[4-(5-pyrimidinyl)phenyl]propanoate C25H32N4O5 详情 详情
(VII) 47705 methyl 2-[[(1-aminocyclopentyl)carbonyl]amino]-3-[4-(5-pyrimidinyl)phenyl]propanoate C20H24N4O3 详情 详情
(VIII) 21056 (R)-(-)-Valine; D-Valine; (R)-alpha-Aminoisovaleric acid 640-68-6 C5H11NO2 详情 详情
(IX) 33158 (2R)-2-bromo-3-methylbutyric acid 565-74-2 C5H9BrO2 详情 详情
(X) 47706 methyl 2-[[(1-[[(2R)-2-bromo-3-methylbutanoyl]amino]cyclopentyl)carbonyl]amino]-3-[4-(5-pyrimidinyl)phenyl]propanoate C25H31BrN4O4 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

Lithiation of 5-bromopyrimidine (I), followed by addition of CO2 produces pyrimidine-5-carboxylic acid (II). After catalytic hydrogenation of (II), the resultant tetrahydropyrimidine acid (III) is esterified with SOCl2 in MeOH to yield the corresponding methyl ester (IV). Protection of (IV) with triphenylmethyl chloride and DBU affords the N-trityl derivative (V). Then, condensation between the sodium derivative of propionamide oxime (VI) and ester (V) gives rise to the oxadiazole compound (VII). The N-trityl group of (VII) is finally removed with trifluoroacetic acid to furnish the title compound.

1 Dunbar, P.G.; Durant, G.J.; Fang, Z.; Abuh, Y.F.; El-Assadi, A.A.; Ngur, D.O.; Periyasamy, S.; Hoss, W.P.; Messer, W.S. Jr.; Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists. J. Med. Chem. 1993, 36, 7, 842.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 38987 5-bromopyrimidine 4595-59-9 C4H3BrN2 详情 详情
(II) 61334 5-pyrimidinecarboxylic acid C5H4N2O2 详情 详情
(III) 61335 1,4,5,6-tetrahydro-5-pyrimidinecarboxylic acid C5H8N2O2 详情 详情
(IV) 61336 methyl 1,4,5,6-tetrahydro-5-pyrimidinecarboxylate C6H10N2O2 详情 详情
(V) 61337 methyl 1-trityl-1,4,5,6-tetrahydro-5-pyrimidinecarboxylate C25H24N2O2 详情 详情
(VI) 61338 N'-hydroxypropanimidamide C3H8N2O 详情 详情
(VII) 61339 5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1-trityl-1,4,5,6-tetrahydropyrimidine C27H26N4O 详情 详情
Extended Information